Abstract:Breast cancer resistance to the antiestrogens tamoxifen (OHT) and fulvestrant is accompanied by alterations in both estrogen-dependent and estrogen-independent signaling pathways. Consequently, effective inhibition of both pathways may be necessary to block proliferation of antiestrogen -resistant breast cancer cells. In this study, we examined the effects of apigenin, a dietary plant flavonoid with potential anticancer properties, on estrogen-responsive, antiestrogen-sensitive MCF7 breast cancer cells and two MCF7 sublines with acquired resistance to either OHT or fulvestrant. We found that apigenin can function as both an estrogen and an antiestrogen in a dose-dependent manner. At low concentrations (1 mu mol/L), apigenin stimulated MCF7 cell growth but had no effect on the antiestrogen-resistant MCF7 sublines. In contrast, at high concentrations (> 10 mu mol/L), the drug inhibited growth of MCF7 cells and the antiestrogen-resistant sublines, and the combination of apigenin with either OHT or fulvestrant showed synergistic, growth-inhibitory effects on both antiestrogen-sensitive and anti estrogen -resistant breast cancer cells. To further elucidate the molecular mechanism of apigenin as either an estrogen or an antiestrogen, effects of the drug on estrogen receptor-alpha (ER alpha); transactivation activity, mobility, stability, and ER alpha-coactivator interactions were investigated. Low-dose apigenin enhanced receptor transcriptional activity by promoting interaction between ER alpha and its coactivator amplified in breast cancer-1. However, higher doses (> 10 mu mol/L) of apigenin inhibited ER alpha mobility (as determined by fluorescence recovery after photobleaching assays), down-regulated ER alpha and amplified in breast cancer-1 expression levels, and inhibited multiple protein kinases, including p38, protein kinase A, mitogen-activated protein kinase, and AKT. Collectively, these results show that apigenin can function as both an antiestrogen and a protein kinase inhibitor with activity against breast cancer cells with acquired resistance to OHT or fulvestrant. We conclude that apigenin, through its ability to target both ER alpha-dependent and ER alpha-independent pathways, holds promise as a new therapeutic agent against antiestrogen-resistant breast cancer.

Apigenin induced MCF-7 cell apoptosis-associated reactive oxygen species.

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Apigenin Induces Protein Kinase B-associated Autophagic Cell Death of Breast Cancer MCF-7 Cell Line

Autophagy Inhibition Enhances Apigenin-Induced Apoptosis in Human Breast Cancer Cells.

Apigenin Induced Apoptosis in Esophageal Carcinoma Cells by Destruction Membrane Structures

Effect of apigenin on the multidrug resistant breast cancer cell line MCF-7/ADR

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

Apigenin Induces Both Intrinsic and Extrinsic Pathways of Apoptosis in Human Colon Carcinoma HCT-116 Cells

Apigenin Induces Apoptosis in Human Lung Cancer H460 Cells Through Caspase- and Mitochondria-Dependent Pathways

Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.

Apigenin Induction of P53-Independent Apoptosis in MDA-MB-231 Breast Cancers

Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns

Apigenin Inhibits Antiestrogen-Resistant Breast Cancer Cell Growth Through Estrogen Receptor-Α-dependent and Estrogen Receptor-Α-independent Mechanisms

Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells

Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of Abt-263

Apigenin 7-O-glucoside promotes cell apoptosis through the PTEN/PI3K/AKT pathway and inhibits cell migration in cervical cancer HeLa cells

Apigenin Attenuates Melanoma Cell Migration by Inducing Anoikis through Integrin and Focal Adhesion Kinase Inhibition

Apigenin Induces Apoptosis in Hep G2 Cells: Possible Role of TNF-α and IFN-γ

Apigenin inhibits renal cell carcinoma cell proliferation.

Apigenin's Modulation of Doxorubicin Efficacy in Breast Cancer

Apigenin role as cell-signaling pathways modulator: implications in cancer prevention and treatment